HPA axis hyperactivity as suicide predictor in elderly mood disorder inpatients

Psychoneuroendocrinology

Volumn 33, Issue 10, 2008, Pages 1387-1393

  Jokinen, Jussi ^a   Nordström, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cortisol; Depression; DST; Elderly; HPA axis; Suicide; Suicide attempt

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

AGED; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DYSTHYMIA; FEMALE; HOSPITAL PATIENT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SUICIDE ATTEMPT;

AGED; CAUSE OF DEATH; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DEXAMETHASONE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MOOD DISORDERS; PITUITARY-ADRENAL SYSTEM; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SUICIDE;

EID: 56249119145     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2008.07.012     Document Type: Article

References (55)

1. Altman D.G., and Bland J.M. Diagnostic tests 1: sensitivity and specificity. BMJ 308 (1994) 1552
2. American Psychiatric Association. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry. Am. J. Psychiatry 144 (1987) 1253-1262
3. Appelhof B.C., Huyser J., Verweij M., Brouwer J.P., van Dyck R., Fliers E., Hoogendijk W.J., Tijssen J.G., Wiersinga M.W., and Schene A.H. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major impression). Biol. Psychiatry 59 8 (2006) 696-701
4. Bao A.M., Meynen G., and Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 57 2 (2007) 531-553
5. Black D.W., Monahan P.O., and Winokur G. The relationship between DST results and suicidal behavior. Ann. Clin. Psychiatry 14 (2002) 83-88
6. Bouix S., Pruessner J.C., Louis Collins D., and Siddiqi K. Hippocampal shape analysis using medial surfaces. Neuroimage 25 (2005) 1077-1089
7. Boza R.A., Milanes F.J., Llorente M., Reisch J., Slater V.L., and Garrigo L. The DST and suicide among depressed alcoholic patients. Am. J. Psychiatry 145 (1988) 266-267
8. Brouwer J.P., Appelhof B.C., van Rossum E.F., Koper J.W., Fliers E., Huyser J., Schene A.H., Tijssen J.G., Van Dyck R., Lamberts S.W., Wiersinga W.M., and Hoogendijk W.J. Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression. Psychoneuroendocrinology 31 10 (2006) 1154-1163
9. Carroll B.J., Martin F.J.R., and Davies B. Resistance to suppression by dexamethasone of plasma 11-OH.C.S. levels in severe depressive illness. Br. Med. J. 3 613 (1968) 285-287
10. Cole M.G., and Dendukuri N. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am. J. Psychiatry 160 (2003) 1147-1156
11. Coryell W., and Schlesser M.A. Suicide and the dexamethasone suppression test in unipolar depression. Am. J. Psychiatry 138 (1981) 1120-1121
12. Coryell W., and Schlesser M. The dexamethasone suppression test and suicide prediction. Am. J. Psychiatry 158 (2001) 748-753
13. Coryell W., Young E., and Carroll B. Hyperactivity of the hypothalamic-pituitary-adrenal axis and mortality in major depressive disorder. Psychiatry Res. 142 1 (2006) 99-104
14. De Kloet E.R., Vreugdenhil E., Oitzl M.S., and Joels M. Brain corticosteroid receptor balance in health and disease. Endocr. Rev. 19 (1998) 269-301
15. de Leon M.J., McRae T., Tsai J.R., George A.E., Marcus D.L., Freedman M., Wolf A.P., and McEwen B. Abnormal cortisol response in Alzheimer's disease linked to hippocampalatrophy. Lancet 2 (1988) 391-392
16. de Leon M.J., McRae T., Rusinek H., Convit A., De Santi S., Tarshish C., Golomb J., Volkow N., Daisley K., Orentreich N., and McEwen B. Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. J. Clin. Endocrinol. Metab. 82 (1997) 3251-3259
17. Dombrovski A.Y., Butters M.A., Reynolds III C.F., Houck P.R., Clark L., Mazumdar S., and Szanto K. Cognitive performance in suicidal depressed elderly: preliminary report. Am. J. Geriatr. Psychiatry 16 2 (2008) 109-115
18. Ershler W.B., and Keller E.T. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty. Annu. Rev. Med. 51 (2000) 245-270
19. Gao S., Hendrie H.C., Hall K.S., and Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch. Gen. Psychiatry 55 (1998) 809-815
20. Gold P.W., and Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Mol. Psychiatry 7 (2002) 254-275
21. Hanley J.A., and McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148 (1983) 839-843
22. Haukka J., Suominen K., Partonen T., and Lönnqvist J. Determinants and outcomes of serious attempted suicide: a nationwide study in Finland 1996-2003. Am. J. Epidemiol. 167 10 (2008) 1155-1163
23. Heuser I.J., Gotthardt U., Schweiger U., Schmider J., Lammers C.H., Dettling M., and Holsboer F. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender. Neurobiol. Aging 15 (1994) 227-231
24. Holsboer F. Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy. J. Affect. Disord. 62 (2001) 77-91
25. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12 (1991) 118-134
26. Jokinen J., Carlborg A., Martensson B., Forslund K., Nordstrom A.L., and Nordstrom P. DST non-suppression predicts suicide after attempted suicide. Psychiatry Res. 150 3 (2007) 297-303
27. Jokinen J., Nordstrom A.L., and Nordstrom P. ROC analysis of dexamethasone suppression test threshold in suicide prediction after attempted suicide. J. Affect. Disord. 106 (2008) 145-152
28. Kajantie E., and Phillips D.I.W. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 31 (2006) 151-178
29. Karvonen K., Räsänen P., Hakko H., Timonen M., Meyer-Rochow V.B., Särkioja T., and Koponen H.J. Suicide after hospitalization in the elderly: a population based study of suicides in Northern Finland between 1988-2003. Int. J. Geriatr. Psychiatry 23 2 (2008) 135-141
30. Keitner G.I., Ryan C.E., Kohn R., Miller I.W., Norman W.H., and Brown W.A. Age and the dexamethasone suppression test: results from a broad unselected patient population. Psychiatry Res. 44 1 (1992) 9-20
31. Laughlin G.A., and Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab. 85 (2000) 3561-3568
32. Lenze E.J., and Mulsant B.H. Biomarkers in geriatric psychiatry. Am. J. Geriatr. Psychiatry 15 (2007) 827-831
33. Li G., Cherrier M.M., Tsuang D.W., Petrie E.C., Colasurdo E.A., Craft S., Schellenberg G.D., Peskind E.R., Raskind M.A., and Wilkinson C.W. Salivary cortisol and memory function in human aging. Neurobiol. Aging 27 (2006) 1705-1714
34. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., and Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1 (1998) 69-73
35. Lupien S.J., Nair N.P., Briere S., Maheu F., Tu M.T., Lemay M., McEwen B.S., and Meaney M.J. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10 (1999) 117-139
36. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., and Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int. J. Neuropsychopharmacol. 21 (2006) 1-10
37. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 23 (2002) 921-939
38. Mossman D., and Somoza E. Maximizing diagnostic information from the dexamethasone suppression test. An approach to criterion selection using receiver operating characteristic analysis. Arch. Gen. Psychiatry 46 7 (1989) 653-660
39. Nordström P., Samuelsson M., and Åsberg M. Survival analysis of suicide risk after attempted suicide. Acta Psychiatr. Scand. 91 (1995) 336-340
40. Norman W.H., Brown W.A., Miller I.W., Keitner G.I., and Overholser J.C. The dexamethasone suppression test and completed suicide. Acta Psychiatr. Scand. 81 (1990) 120-125
41. Otte C., Jahn H., Yassouridis A., Arlt J., Stober N., Maass P., Wiedemann K., and Kellner M. The mineralocorticoid receptor agonist, fludrocortisone, inhibits pituitary-adrenal activity in humans after pre-treatment with metyrapone. Life Sci. 73 (2003) 1835-1845
42. Otte C., Hart S., Neylan T.C., Marmar C.R., Yaffe K., and Mohr D.C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 30 1 (2005) 80-91
43. Reynolds R.M., Syddall H.E., Walker B.R., Wood P.J., and Phillips D.I. Predicting cardiovascular risk factors from plasma cortisol measured during oral glucose tolerance tests. Metabolism 52 (2003) 524-527
44. Rosmond R., Dallman M.F., and Bjorntorp P. Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J. Clin. Endocrinol. Metab. 83 (1998) 1853-1859
45. Roy A., Ågren H., Pickar D., Linnoila M., Doran A., Cutler N., and Paul S.M. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Am. J. Psychiatry 143 (1986) 1539-1545
46. Sapolsky R.M., Krey L.C., and McEwen B.S. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7 (1986) 284-301
47. Schaaf M.J., De Kloet E.R., and Vreugdenhil E. Corticosterone effects on BDNF expression in the hippocampus. Implications for memory formation. Stress 3 (2000) 201-208
48. Suominen K., Isometsä E., Haukka J., and Lönnqvist J. Substance use and male gender as risk factors for deaths and suicide. A 5-year follow-ip study after deliberate self-harm. Soc. Psychiatry Psychiatr. Epidemiol. 39 (2004) 720-724
49. Targum S.D., Rosen L., and Capodanno A.E. The dexamethasone suppression test in suicidal patients with unipolar depression. Am. J. Psychiatry 140 (1983) 877-879
50. Traskman L., Asberg M., Bertilsson L., and Sjostrand L. Monoamine metabolites in CSF and suicidal behaviour. Arch. Gen. Psychiatry 38 (1981) 631-636
51. Waern M., Runeson B., Allebeck P., Beskow J., Rubenowitz E., Skoog I., and Wilhelmsson K. Mental disorder in elderly suicides: a case-control study. Am. J. Psychiatry 159 (2002) 450-455
52. Wolf O.T., Convit A., de Leon M.J., Caraos C., and Qadri S.F. Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes. Neuroendocrinology 75 (2002) 241-249
53. Yerevanian B.I., Olafsdottir H., Milanese E., Russotto J., Baciewicz G., and Sagi E. Normalization of the Dexamethasone Suppression Test at discharge from hospital. Its prognostic value. J. Affect. Disord. 5 (1983) 191-197
54. Yerevanian B.I., Feusner J.D., Koek R.J., and Mintz J. The dexamethasone suppression test as a predictor of suicidal behaviour in unipolar depression. J. Affect. Disord. 83 (2004) 103-108
55. Zweig M.H., and Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39 4 (1993) 561-577